leisure time -WSS

leisure time

author：entertainment 2025-09-28 23:24:26 - browse：9

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Decaf coffee targeted by food safety group under obscure FDA rule

hotspot

WSS

Study says nonprofit hospitals fall short in charity care spending

Washington mulls new rules to avert another Change Healthcare

Why the world’s most expensive drug might be worth the price

Readout Newsletter: Merck, Vertex, and Viking updates

Democrats decry new health bill for going easy on private equity

UHS says company favors patients whose insurance pays more

leisure time

leisure time

Wikipedia

Guidelines to prevent youth baseball injuries need more muscle

UHS says company favors patients whose insurance pays more

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Roche subsidiary Foundation Medicine opens new headquarters

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Readout LOUD podcast: mifepristone case, GLP

The cancer drug shortage isn’t new — and neither are the solutions

Washington mulls new rules to avert another Change Healthcare

Peter Hotez and the public health issue of online harassment

The battle over 'scope creep' and who gets to be called 'doctor'

hotspot

Biogen says it will cut costs by $700 million, slash 1,000 jobs

New lawsuit accuses health insurer Cigna of denying claims in bulk

New Alzheimer's drugs heat up race for early detection blood tests

Oprah kicked off a national conversation on obesity. Let's have it

What it's like to live with paralysis for one psychologist

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

explore

explore

hotspot

focus